Progress with COVID vaccine development and implementation.

Titball, Richard W; Bernstein, David I; Fanget, Nicolas V J; Hall, Roy A; Longet, Stephanie; MacAry, Paul A; Rupp, Richard E; van Gils, Marit; von Messling, Veronika; Walker, David H; Barrett, Alan D T.

Afiliação

Titball RW; Department of Biosciences, University of Exeter, Devon, UK. R.W.Titball@exeter.ac.uk.
Bernstein DI; Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH, USA.
Fanget NVJ; Nature Research, London, UK.
Hall RA; Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD, Australia.
Longet S; CIRI - Centre International de Recherche en Infectiologie, Team GIMAP, Univ Lyon, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR5308, CIC 1408 Vaccinology, F42023, Saint-Etienne, France.
MacAry PA; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Rupp RE; Department of Pediatrics, University of Texas Medical Branch, Galveston, TX, USA.
van Gils M; Department of Medical Microbiology and Infection Prevention, Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
von Messling V; Federal Ministry of Education and Research, Berlin, Germany.
Walker DH; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.
Barrett ADT; Sealy Institute for Vaccine Sciences and Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.

NPJ Vaccines ; 9(1): 69, 2024 Apr 01.

Article em En | MEDLINE | ID: mdl-38561358

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article